|
|
 |
Clinical Trials
»‘Raising the Bar’ through Clinical Trials
»A Large Patient Population
»Getting Started…
»Clinical Trial Phases
»Major Successes
A Large Patient Population
The Princess Margaret is fortunate to be located at the heart of a large cosmopolitan city, which makes it ideal for clinical trials. Dr. Mary Gospodarowicz, head of the Cancer Program for The Princess Margaret, says that in addition to being able to draw from a large population that is ethnically diverse, “The Princess Margaret has the internal breadth and depth to make it one of the most comprehensive cancer centres in the world. There are very few cancer situations that we are not equipped to treat.”
The clinical trials at Princess Margaret are spread across many disease sites, and a large number of trials involve multiple disease sites.
| Disease Site |
Number of Open Trials |
| Breast |
29 |
| Gastrointestinal |
34 |
| Gynecological |
29 |
| Head & Neck |
26 |
| Leukemia |
44 |
| Lung |
37 |
| Lymphoma |
24 |
| Skin/Sarcoma |
4 |
| Urology |
66 |
| Central Nervous System |
7 |
| Endocrine |
3 |
| Multiple Disease Sites |
56 |
Almost two-thirds of the clinical trials test new drug treatments and are run by the department of Medical Oncology, while just under 100 trials are run by the department of Radiation Oncology, and about 40 are run by the department of Surgical Oncology.
|
|
|
Read about one of the leaders in clinical trials at PMH
View a presentation on Drug Trials by Dr. Lillian Siu
Read about a patient who participated in a clinical trial of a new drug for leukemia
Find out how you can support clinical trials at PMH |
|
|